169 related articles for article (PubMed ID: 34051617)
1. Theobroma cacao L. compounds: Theoretical study and molecular modeling as inhibitors of main SARS-CoV-2 protease.
Yañez O; Osorio MI; Areche C; Vasquez-Espinal A; Bravo J; Sandoval-Aldana A; Pérez-Donoso JM; González-Nilo F; Matos MJ; Osorio E; García-Beltrán O; Tiznado W
Biomed Pharmacother; 2021 Aug; 140():111764. PubMed ID: 34051617
[TBL] [Abstract][Full Text] [Related]
2. In Silico Evaluation of Iranian Medicinal Plant Phytoconstituents as Inhibitors against Main Protease and the Receptor-Binding Domain of SARS-CoV-2.
Mousavi SS; Karami A; Haghighi TM; Tumilaar SG; Fatimawali ; Idroes R; Mahmud S; Celik I; Ağagündüz D; Tallei TE; Emran TB; Capasso R
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577194
[TBL] [Abstract][Full Text] [Related]
3.
Alesawy MS; Elkaeed EB; Alsfouk AA; Metwaly AM; Eissa IH
Molecules; 2021 Oct; 26(21):. PubMed ID: 34771004
[TBL] [Abstract][Full Text] [Related]
4. Are vanadium complexes druggable against the main protease M
Scior T; Abdallah HH; Mustafa SFZ; Guevara-García JA; Rehder D
Inorganica Chim Acta; 2021 May; 519():120287. PubMed ID: 33589845
[No Abstract] [Full Text] [Related]
5. Drugs Repurposing Using QSAR, Docking and Molecular Dynamics for Possible Inhibitors of the SARS-CoV-2 M
Tejera E; Munteanu CR; López-Cortés A; Cabrera-Andrade A; Pérez-Castillo Y
Molecules; 2020 Nov; 25(21):. PubMed ID: 33172092
[TBL] [Abstract][Full Text] [Related]
6. Synthetic flavonoids as potential antiviral agents against SARS-CoV-2 main protease.
Batool F; Mughal EU; Zia K; Sadiq A; Naeem N; Javid A; Ul-Haq Z; Saeed M
J Biomol Struct Dyn; 2022 May; 40(8):3777-3788. PubMed ID: 33251983
[TBL] [Abstract][Full Text] [Related]
7.
Kumar B; Parasuraman P; Murthy TPK; Murahari M; Chandramohan V
J Biomol Struct Dyn; 2022 Oct; 40(17):7796-7814. PubMed ID: 33759690
[TBL] [Abstract][Full Text] [Related]
8.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
9. Investigation of angucycline compounds as potential drug candidates against SARS Cov-2 main protease using docking and molecular dynamic approaches.
Al-Bustany HA; Ercan S; Ince E; Pirinccioglu N
Mol Divers; 2022 Feb; 26(1):293-308. PubMed ID: 33837893
[TBL] [Abstract][Full Text] [Related]
10. In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2.
Abdizadeh R; Hadizadeh F; Abdizadeh T
Mol Divers; 2022 Apr; 26(2):1053-1076. PubMed ID: 34213728
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for the inhibition of SARS-CoV2 main protease by Indian medicinal plant-derived antiviral compounds.
Saravanan KM; Zhang H; Senthil R; Vijayakumar KK; Sounderrajan V; Wei Y; Shakila H
J Biomol Struct Dyn; 2022 Mar; 40(5):1970-1978. PubMed ID: 33073712
[TBL] [Abstract][Full Text] [Related]
12. Computational Selectivity Assessment of Protease Inhibitors against SARS-CoV-2.
Fischer A; Sellner M; Mitusińska K; Bzówka M; Lill MA; Góra A; Smieško M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669738
[TBL] [Abstract][Full Text] [Related]
13. Potential inhibitors of the main protease of SARS-CoV-2 and modulators of arachidonic acid pathway: Non-steroidal anti-inflammatory drugs against COVID-19.
Sisakht M; Solhjoo A; Mahmoodzadeh A; Fathalipour M; Kabiri M; Sakhteman A
Comput Biol Med; 2021 Sep; 136():104686. PubMed ID: 34340125
[TBL] [Abstract][Full Text] [Related]
14. First COVID-19 molecular docking with a chalcone-based compound: synthesis, single-crystal structure and Hirshfeld surface analysis study.
Alsafi MA; Hughes DL; Said MA
Acta Crystallogr C Struct Chem; 2020 Dec; 76(Pt 12):1043-1050. PubMed ID: 33273140
[TBL] [Abstract][Full Text] [Related]
15. Molecular docking and simulation studies of natural compounds of
Mitra D; Verma D; Mahakur B; Kamboj A; Srivastava R; Gupta S; Pandey A; Arora B; Pant K; Panneerselvam P; Ghosh A; Barik DP; Mohapatra PKD
J Biomol Struct Dyn; 2022 Aug; 40(12):5665-5686. PubMed ID: 33459176
[TBL] [Abstract][Full Text] [Related]
16. Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic.
Fakhar Z; Faramarzi B; Pacifico S; Faramarzi S
J Biomol Struct Dyn; 2021 Oct; 39(16):6171-6183. PubMed ID: 32741312
[TBL] [Abstract][Full Text] [Related]
17.
Kumar R; Kumar R; Tanwar P
J Biomol Struct Dyn; 2022 Oct; 40(16):7394-7407. PubMed ID: 33715592
[TBL] [Abstract][Full Text] [Related]
18. Dual inhibition of SARS-CoV-2 spike and main protease through a repurposed drug, rutin.
Kumari A; Rajput VS; Nagpal P; Kukrety H; Grover S; Grover A
J Biomol Struct Dyn; 2022 Jul; 40(11):4987-4999. PubMed ID: 33357073
[TBL] [Abstract][Full Text] [Related]
19. Computational Insights on the Potential of Some NSAIDs for Treating COVID-19: Priority Set and Lead Optimization.
Abo Elmaaty A; Hamed MIA; Ismail MI; B Elkaeed E; S Abulkhair H; Khattab M; Al-Karmalawy AA
Molecules; 2021 Jun; 26(12):. PubMed ID: 34205704
[TBL] [Abstract][Full Text] [Related]
20. Molecular modelling on SARS-CoV-2 papain-like protease: an integrated study with homology modelling, molecular docking, and molecular dynamics simulations.
Arwansyah A; Arif AR; Ramli I; Kurniawan I; Sukarti S; Nur Alam M; Illing I; Farid Lewa A; Manguntungi B
SAR QSAR Environ Res; 2021 Sep; 32(9):699-718. PubMed ID: 34392751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
